Jupiter Merian European Equity (Ex UK) I

Aims for long term capital growth.

  • 223.90p
    Price (Inc)

    These are the shares in the fund that pay out an income to clients. The income is made up of the total dividends – the money a company can pay out to its investors – from the companies in the fund.

  • -
    Price (Acc)

    These are the shares in the fund that don’t pay out an income to clients. Any dividends – the money a company can pay out to its investors – are reinvested into companies in the fund. Despite no income, the shares should be worth more over time. Good incentive, eh?

  • 0.00%

    Initial charge

    Some funds charge you when you first invest, which is aptly known as the initial charge. They’re usually between 3-5% but at Bestinvest, we usually don’t charge you a penny!

  • 0.90%
    Annual management charge

    This is how much the fund management company charges to run the fund. It’s like paying a babysitter, dog sitter or house sitter (that makes well-informed, heavily researched changes to improve your baby/dog/house when needed).

  • 0.90%
    Ongoing charges

    This stands for Ongoing Charges Figure. It’s the cost of running a fund and includes admin fees, manager fees, administration costs, etc.

  • 0.00%

    How much the fund is currently paying out in income to investors. It’s NOT to be confused with the overall growth of a fund – a very different thing indeed. It’s also NOT a guarantee of future pay-outs, just a snapshot. This is more what it’s not than what it is…

Prices as at 30 July 2021

The Fund's objective is to achieve long-term capital growth through the active management of a diversified portfolio invested primarily in European stock markets excluding the United Kingdom.

Fund summary

Sector Europe Excluding UK
Structure OEIC
Launched November, 2012
Size £37m
Yield 0.00%
Charging basis Income
Dividends paid Acc units only


Standard initial charge 0.00%
Initial charge via Bestinvest 0.00%
Additional bid/offer spread 0.00%
Annual management charge 0.90%
Ongoing charges figure 0.90%


Proportion (%)

  • {{chartDataItem.text}}


Proportion (%)

  • {{chartDataItem.text}}


Proportion (%)

  • {{chartDataItem.text}}

Investment process

Manager research

Average monthly relative returns

  • 16/17 0.39%
  • 17/18 0.35%
  • 18/19 -0.51%
  • 19/20 -0.23%
  • 20/21 0.19%

Bestinvest MRI

  • 3 years -0.19%
  • 5 years 0.04%
  • Career 0.06%
  • 3 years 26.40%
  • 5 years 83.20%
  • Career 95.20%

Performance figures are based on the average of monthly percentage returns relative to the benchmark index.

Merian Quantitative Strategies Team

The team is managed by Ian Heslop as Head of Quantitative Strategies. He joined OMGI in 2000 and was previously at Barclays Global Investors. He has a BA in Chemistry from Oxford; a PhD in Chemistry from Edinburgh and is an Associate of the UK Society of Investment Professionals. Other members of the team include: Amadeo Alentorn, Head of Quantitative Research who joined OMGI in 2005 from the Bank of England; Mike Servent, Head of Quantitative Modelling & Systems, who joined OMGI in 2004 from BARRA and COR Risk Solutions; Yuangao Liu, Quantitative Analyst, who joined OMGI in 2007 from Jacobs UK; Lawrence Clarke, Quantitative Developer, who joined OMGI in 2006.

Track record

Merian Quantitative Strategies Team has 17.2 years experience of managing mutual funds in this sector. Over this period the average monthly return relative to the benchmark index has been +0.06%. During the worst period of relative performance (from April 2007 - August 2010) there was a decline of 20% relative to the index. The worst absolute loss has been 41%. Statistically, we estimate the probability that this fund manager is adding value, rather than being lucky, is 95%.

Periods of worst performance

Absolute -41.00% (May 2007 - February 2009)
Relative -20.00% (April 2007 - August 2010)

About the MRI

Our unique indicator: the Bestinvest Manager Record Index (MRI) measures the likelihood that the fund manager is adding value through their decisions. It is based on their performance record over the course of their career, adjusted for the amount of risk taken. MRI is an important contributor to our fund rating system but it is also vital to take account of qualitative factors. It is also very important to select funds to form a cohesive portfolio with an appropriate overall risk level.


Proportion (%)

  • {{chartDataItem.text}}


Proportion (%)

  • {{chartDataItem.text}}


Proportion (%)

  • {{chartDataItem.text}}

Top 10 holdings

Data accurate as at 31 July 2020

4.6% Roche Hldg Ag
4.2% Nestle Sa
3.6% Novartis Ag
2.7% Novo-Nordisk As
2.6% L`Oreal
2.4% Asml Holding Nv
2.3% Schneider Electric Se
2.3% Allianz Se
1.7% Munich Reinsurance Company
1.6% Genmab As
Source: Trustnet

Sector breakdown

Health Care 20.00%
Industrials 17.00%
Financials 17.00%
Consumer Staples 11.00%
Information Technology 9.00%
Utilities 7.00%
Consumer Discretionary 6.00%
Materials 5.00%
Communications 4.00%
Money Market 2.00%

Key Investor Information